Janux Therapeutics logo

Janux Therapeutics

1 follower

Janux Therapeutics is developing safe, effective novel immunotherapies with the company’s proprietary TRACTr technology. Janux’s TRACTr technology employs a modular design to rapidly engineer drug candidates against specific targets.

Industries

Employees

51-200

Links


Org chart

David Campbell
President & CEO
Collapse
Byron Robinson
Chief Strategy Officer
Sandy Seril
Executive Assistant
Mandie Forman-Sklansky
Executive Director, Head Of HR
Janeen Doyle
Chief Corporate And Business Development Officer
Carolina Caffaro
Vice President, CMC
Sara Walsh
Executive Administrative Assistant to the President and Chief Executive Officer
Megan Shannon
Executive Director, Clinical Science
Jenna Daly
Executive Director Clinical Operations
Kevin Watt
Vice President, Program and Portfolio Management
James Pennington
General Counsel
Tighe Reardon
Acting CFO
William Go MD
Chief Medical Officer

Board & advisors

Ron Barrett
Director
Winston Kung
Director
Jay Lichter
Chairperson
Jake Simson
Director
Vickie Capps
Director
Greg Weiss
Advisor